Sale!

Tesamorelin 10mg

$59.00

Tesamorelin is a synthetic 44-amino acid peptide research reagent for receptor binding and SAR analysis. ≥99% pure (HPLC verified), sterile lyophilized powder.

6 in stock

Vials Discount
2 - 10 10%
11 - 20 20%
21 + 30%

Third-Party Tested

Verified purity and quality standards.

Fast U.S. Shipping

Reliable delivery from our U.S. base.

Secure & Trusted

Safe and secure shopping with trusted payment protection.

Tesamorelin Research Peptide Overview

Tesamorelin Research Peptide is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone, or GHRH. Researchers use this compound in controlled laboratory studies involving peptide-receptor binding, structure-activity relationships, intracellular signaling, molecular stability, and analytical characterization.

Because Tesamorelin is structurally related to GHRH, researchers can use it as a model for examining GHRH receptor interactions. In addition, its defined peptide structure allows scientists to study how molecular modifications influence receptor recognition and peptide stability.

Therefore, Tesamorelin Research Peptide provides a useful comparison compound for laboratories studying GHRH-related peptides. Researchers can compare it with other analogues while carefully accounting for differences in sequence, structure, and experimental design.

GHRH Receptor Research

Published research has examined the molecular biology of the GHRH receptor, or GHRH-R. This receptor belongs to the G protein-coupled receptor family and participates in several intracellular signaling pathways.

For example, researchers can examine peptide binding to GHRH receptors in controlled cell-based or receptor-based systems. In addition, scientists may compare binding affinity across related peptide analogues.

Structure-activity studies are especially useful in this area. Researchers can change peptide sequence or molecular structure and then measure how those changes influence receptor recognition.

However, receptor-binding results depend heavily on the experimental model. Therefore, researchers should document receptor expression, cell type, peptide concentration, incubation time, and assay conditions.

Intracellular Signaling Research

GHRH receptor activation is associated with intracellular signaling pathways that include cyclic adenosine monophosphate, commonly called cAMP.

Therefore, researchers studying Tesamorelin may examine cAMP-related signaling in suitable laboratory models. For example, scientists can measure changes in second-messenger activity after exposing receptor-expressing cells to a test compound.

In addition, researchers may use reporter-gene systems or other cellular assays to compare downstream molecular responses. These methods can help connect receptor interaction with measurable intracellular signaling.

Moreover, scientists may compare Tesamorelin with other GHRH-related peptides under identical conditions. As a result, laboratories can examine whether structural differences produce measurable changes in signaling activity.

Structure-Activity Relationship Research

Tesamorelin Research Peptide can also support structure-activity relationship, or SAR, studies.

Researchers have long examined relationships between GHRH analogue structure, receptor-binding affinity, and measurable activity. For example, changes to individual amino acids can influence peptide conformation and receptor interaction.

Therefore, Tesamorelin may serve as one reference point in comparative GHRH analogue research. Scientists can compare its molecular characteristics with shorter GHRH fragments or modified analogues.

In addition, researchers may investigate how peptide length affects receptor binding. Full-length GHRH-related sequences and shorter fragments can behave differently in controlled experimental systems.

As a result, SAR research can help identify structural features that contribute to molecular recognition and receptor activation.

Peptide Stability and Degradation Research

Peptide stability represents another important area of Tesamorelin research.

For example, laboratories can investigate how temperature, pH, buffer composition, and storage conditions affect molecular stability. Researchers may also monitor changes that occur over different time periods.

In addition, scientists can investigate peptide degradation products. These experiments may help researchers identify molecular regions that are more susceptible to enzymatic or chemical modification.

Comparative stability studies can also include related GHRH analogues. Therefore, researchers can evaluate whether structural modifications alter degradation patterns under controlled laboratory conditions.

However, stability results from one experimental environment should not automatically be applied to another. Researchers should document all preparation, handling, and storage conditions.

Analytical Testing and Mass Spectrometry

Analytical laboratories can characterize Tesamorelin with chromatographic and mass-spectrometry techniques.

High-performance liquid chromatography, or HPLC, can help researchers evaluate sample composition and separate the target peptide from related compounds or degradation products.

In addition, liquid chromatography combined with mass spectrometry can provide detailed molecular identification. Recent analytical research has specifically included Tesamorelin alongside Sermorelin and CJC-1295.

For example, researchers have developed UHPLC-MS/MS methods for detecting and characterizing GHRH analogues. More recently, investigators have also evaluated nano-liquid chromatography combined with quadrupole-Orbitrap mass spectrometry.

Therefore, Tesamorelin provides a useful analytical reference compound for laboratories studying peptide separation, detection, stability, and molecular identity.

Comparative GHRH Peptide Research

Researchers may compare Tesamorelin with several other peptides involved in GHRH-related research.

For example, Sermorelin represents the shorter GHRH(1-29) sequence. Therefore, comparing Sermorelin and Tesamorelin can help researchers investigate differences associated with peptide length and molecular structure.

Likewise, CJC-1295 is a modified GHRH analogue. Researchers may compare its structural modifications with Tesamorelin when studying receptor affinity and molecular stability.

Ipamorelin, however, belongs to a different peptide class and interacts with a different receptor system. As a result, comparing Ipamorelin with Tesamorelin may help researchers distinguish between different receptor-mediated signaling pathways.

Finally, multi-peptide preparations such as CJC-1295 + Ipamorelin provide another model for comparative molecular-interaction research. However, researchers should evaluate each component independently before interpreting combined experimental results.

Tesamorelin Research Applications

Researchers may investigate Tesamorelin in areas such as:

  • GHRH receptor-binding research
  • Peptide-receptor interaction studies
  • Structure-activity relationship analysis
  • cAMP-associated signaling research
  • Cell-based reporter assays
  • Comparative GHRH analogue research
  • Molecular stability studies
  • Peptide degradation analysis
  • Molecular structure-function research
  • HPLC analytical testing
  • UHPLC-MS/MS analysis
  • High-resolution mass-spectrometry characterization

Related Research Peptides

Researchers comparing Tesamorelin Research Peptide may also explore:

  • Sermorelin 5mg — GHRH(1-29) receptor-binding, structure-activity, and comparative peptide research.
  • CJC 1295 w/DAC 5mg — modified GHRH-analogue receptor binding, peptide stability, and molecular half-life research.
  • Ipamorelin 10mg — receptor-selectivity, peptide-binding, and comparative signaling research.
  • CJC-1295 + Ipamorelin 10mg — dual-peptide molecular-interaction, receptor-binding, and comparative signaling research.

Published Tesamorelin Research

Tesamorelin as a GHRH(1-44) Analogue

View Tesamorelin GHRH Research on PubMed

This PubMed-indexed study identifies Tesamorelin as a GHRH(1-44) analogue and provides scientific context for research involving GHRH-associated molecular pathways.

GHRH Receptor Signaling

View GHRH Receptor Signaling Research on PubMed

This publication reviews GHRH receptor structure and molecular signaling. In addition, it describes receptor-associated pathways that include cAMP signaling.

GHRH Structure and Receptor-Binding Research

View GHRH Analogue Structure-Activity Research on PubMed

This study examined relationships between GHRH analogue structure, receptor-binding affinity, and molecular activity. Therefore, it provides useful background for comparative GHRH peptide research.

Tesamorelin UHPLC-MS/MS Research

View GHRH Analogue UHPLC-MS/MS Research on PubMed

This publication describes an analytical UHPLC-MS/MS method that included Tesamorelin and other GHRH-related peptides. Researchers evaluated detection, stability, recovery, and analytical performance.

Tesamorelin High-Resolution Mass-Spectrometry Research

View GHRH Analogue Orbitrap-MS Research on PubMed

This study evaluated Tesamorelin, Sermorelin, CJC-1295, and related GHRH compounds using nano-liquid chromatography combined with quadrupole-Orbitrap mass spectrometry.

Experimental Considerations

Different laboratory models answer different research questions. For example, receptor-binding assays examine direct molecular interactions, while cell-based experiments can measure downstream signaling.

Therefore, researchers should clearly identify the experimental system when interpreting Tesamorelin data. In addition, scientists should avoid directly applying findings from one model to another.

Laboratory conditions can also influence experimental outcomes. For example, temperature, peptide concentration, exposure time, buffer composition, receptor expression, and sample preparation may affect measured results.

Moreover, researchers should include appropriate controls and document analytical methods. Careful experimental design can help separate true molecular responses from changes caused by sample handling or assay conditions.

Encompass Peptides supplies Tesamorelin 10mg exclusively for controlled laboratory investigation and analytical research.

Research Use Statement

For In Vitro Research Use Only. Encompass Peptides designates this material exclusively for controlled laboratory investigation. Published references provide scientific and educational context only. They do not establish the safety, efficacy, identity, or suitability of this research material for human or veterinary use.